host
cell
evolv
numer
innat
defens
viru
infect
includ
collect
constitut
express
antivir
restrict
factor
varieti
special
respons
induc
viral
infect
major
compon
induc
innat
immun
respons
viral
infect
activ
antivir
interferon
ifn
transcript
induc
hundr
interferonstimul
gene
isg
isg
vari
function
includ
regul
ifn
respons
altern
encod
effector
molecul
directli
inhibit
viral
infect
collect
isg
respons
facilit
clearanc
viru
infect
cell
establish
protect
antivir
state
uninfect
cell
promot
adapt
immun
respons
samuel
isg
induc
across
numer
cell
type
speci
howev
function
character
rel
limit
isg
function
character
frequent
target
conserv
aspect
viru
infect
includ
isg
impact
integr
nucleic
acid
oligoisoadenyl
synthetas
oa
ribonucleas
rnase
l
pathway
adenosin
deaminas
rnaspecif
adar
apiloprotein
b
mrna
edit
enzym
catalyt
polypeptid
apobec
protein
translat
protein
kinas
r
pkr
virion
bud
bone
marrow
stromal
cell
antigen
tetherin
sadler
william
function
screen
approach
includ
isg
overexpress
knockdown
screen
use
catalog
broader
rang
put
ifninduc
antivir
effector
ablass
hornung
fusco
et
al
karki
et
al
liu
et
al
metz
et
al
schoggin
et
al
zhao
et
al
respect
function
newli
defin
antivir
effector
isg
like
target
expand
repertoir
virushost
interact
lipid
facilit
stage
viral
life
cycl
includ
initi
interact
virion
host
cell
envelop
fusion
modif
cellular
membran
establish
site
replic
andor
assembl
cellular
metabol
coordin
virion
assembl
bud
review
heaton
randal
attract
target
innat
immun
defens
develop
therapeut
exampl
mani
virus
requir
fatti
acid
biosynthesi
replic
assembl
review
chukkap
et
al
amp
kinas
isg
limit
viral
replic
inhibit
ratelimit
enzym
fatti
acid
biosynthesi
acetyl
coenzym
coa
carboxylas
moser
et
al
inde
one
extens
character
isg
viperin
modul
viru
infect
impact
lipid
multipl
way
human
cytomegaloviru
hcmv
coopt
viperin
inhibit
lipid
boxid
turn
stimul
lipid
biogenesi
support
virion
envelop
viperin
also
inhibit
isoprenoid
synthesi
disrupt
lipid
raft
turn
limit
viru
infect
requir
lipid
raft
viru
entri
bud
review
seo
et
al
major
lipiddepend
interact
envelop
viru
infect
fusion
virion
lipid
bilay
cellular
membran
releas
viral
genom
cytoplasm
review
plemper
occur
either
plasma
membran
distinct
endosom
compart
govern
part
ph
depend
viral
fusion
apparatu
gener
fusion
occur
interact
viral
envelop
protein
host
cell
produc
conform
chang
viral
fusion
protein
expos
fusion
peptid
gener
suffici
free
energi
facilit
membran
fusion
inher
energet
unfavor
event
case
virus
fuse
plasma
membran
conform
chang
fusion
protein
occur
receptor
engag
suffici
drive
fusion
virus
fuse
endosom
compart
proton
fusion
protein
occur
acidifi
endocyt
ph
frequent
promot
fusion
addit
endosom
lysosom
proteas
cleav
fusion
protein
altern
endosom
lipid
andor
protein
receptor
promot
fusion
process
plemper
fusion
protein
posit
viral
envelop
close
proxim
cellular
membran
hemifus
outer
leaflet
viral
cellular
lipid
bilay
fuse
occur
figur
follow
hemifus
earli
fusion
pore
form
enlarg
late
fusion
pore
viral
nucelocapsid
releas
cytoplasm
import
review
fusion
process
hemifus
particular
sensit
lipid
composit
membran
affect
membran
curvatur
fluiditi
figur
modul
membran
lipid
composit
viabl
approach
inhibit
virion
fusion
review
discuss
number
recent
discoveri
character
host
restrict
viral
infect
especi
virion
fusion
modifi
pathway
synthes
process
transport
lipid
alter
membran
composit
recent
studi
microarray
profil
macrophag
either
treat
ifng
infect
murin
cytomegaloviru
mcmv
identifi
repress
sterol
biosynthet
pathway
signific
compon
ifn
antivir
effect
blanc
et
al
consequ
repress
sterol
biosynthet
gene
express
reduct
level
cellular
cholesterol
class
drug
known
statin
impair
cholesterol
synthesi
inhibit
hmgcoa
reductas
enzym
requir
synthesi
cholesterol
intermedi
mevalon
cell
treat
simvastatin
resist
mcmv
cultur
cell
mevalon
cholesterol
revers
resist
silenc
either
hmgcr
two
gene
encod
enzym
sterol
biosynthesi
result
decreas
mcmv
infect
collect
studi
point
role
proxim
mevalon
arm
sterol
biosynthesi
cholesterol
regul
mcmv
infect
figur
author
hypothes
requir
prenyl
viral
andor
cellular
protein
mcmv
infect
repress
sterol
biosynthesi
ifn
appear
occur
via
reduc
express
sterol
regulatori
element
bind
protein
transcript
regul
sterol
biosynthesi
mcmvinfect
mice
treat
simvastatin
reduct
viral
titer
spleen
liver
kidney
heart
lung
studi
probe
antivir
mechan
underli
observ
defin
role
oxysterol
antivir
sterollipid
effector
one
sever
natur
occur
oxysterol
deriv
cholesterol
contain
hydroxyl
group
side
chain
cholesterol
mice
human
catalyz
synthesi
cholesterol
increasingli
implic
modul
host
immun
multipl
level
exampl
shown
suppress
product
immunoglobulin
iga
b
cell
mice
increas
iga
level
serum
bauman
et
al
also
implic
suppress
differenti
monocyt
macrophag
ecker
et
al
dendrit
cell
macrophag
upregul
respons
type
ifn
suggest
potenti
role
innat
immun
park
scott
overexpress
screen
design
identifi
ifninduc
antivir
effector
uncov
antivir
role
liu
et
al
ectop
express
cell
confer
strong
antivir
effect
two
envelop
virus
dna
viru
murin
gamma
herpesviru
rna
viru
vesicular
stomat
viru
vsv
followup
studi
group
character
mechan
antivir
activ
liu
et
al
use
either
shrnamedi
knockdown
cell
mice
show
optim
control
vsv
replic
requir
seri
media
transfer
experi
demonstr
express
produc
solubl
antivir
factor
type
ifn
thu
author
examin
natur
product
activ
inde
exogen
addit
cell
suppress
vsv
infect
remark
panantivir
viral
fusion
protein
shown
bring
membran
close
apposit
thu
promot
hairpin
format
hemifus
occur
wherein
outer
leaflet
bilay
fuse
produc
stalk
conform
induc
neg
membran
curvatur
elong
diaphragm
conform
inner
leaflet
align
follow
pore
format
result
deliveri
nucleocapsid
cytoplasm
b
lipid
promot
neg
membran
curvatur
membran
fluiditi
pe
cholesterol
facilit
fusion
lipid
promot
posit
curvatur
rigid
inhibitori
fusion
review
teissier
cheur
fatti
acid
hydroxyl
mevalon
synthesi
multipl
downstream
effect
includ
cholesterol
synthesi
protein
prenyl
geranylgeranyl
synthesi
dolichol
sterol
heme
ubiquinon
shown
cholesterol
convert
virusmedi
interferon
induct
lead
synthesi
macrophag
put
antivir
mechan
dash
red
line
includ
direct
effect
virion
fusion
host
cell
indirect
effect
mediat
modul
target
gene
select
target
gene
green
arrow
shown
ital
effect
demonstr
panel
envelop
virus
includ
herp
simplex
viru
ebolaviru
rift
valley
fever
viru
nipah
viru
effect
nonenvelop
adenoviru
suggest
antivir
effect
may
specif
envelop
virus
although
nonenvelop
virus
remain
character
antivir
potenc
variabl
depend
viru
effect
viral
titer
rang
antivir
effect
vsv
infect
select
rel
oxysterol
independ
known
function
includ
regul
mevalon
product
protein
prenyl
liu
et
al
impair
vsv
hiv
bind
rather
inhibit
viruscel
fusion
affect
properti
cellular
membran
cellcel
membran
fusion
assay
use
nipah
viru
fusion
f
attach
g
protein
shown
reduc
syncytia
format
surrog
assay
suggest
similar
mechan
may
oper
viralhost
membran
interfac
antivir
effect
vsv
could
compet
incub
vsv
inoculum
artifici
liposom
contain
lipid
content
similar
cellular
membran
rescu
experi
suggest
directli
alter
cellular
membran
therebi
interf
viru
entri
figur
lastli
inhibit
hiv
human
mous
model
mice
suscept
wildtyp
mice
therebi
solidifi
import
oxysterol
pathway
innat
antivir
immun
vivo
liu
et
al
also
uncov
ifninduc
antivir
molecul
use
distinct
metabolom
approach
blanc
et
al
liquid
chromatographymass
spectrometri
lcm
analysi
oxysterol
select
identifi
upregul
mous
macrophag
either
viral
infect
ifn
treatment
similar
result
liu
et
al
author
demonstr
exogen
antivir
effect
panel
envelop
virus
effect
adenoviru
dissect
select
enantiom
test
effect
viral
growth
compound
also
abl
suppress
viral
infect
high
concentr
author
conclud
enantioselect
antivir
action
may
suggest
addit
membraneindepend
function
although
entri
inhibit
envelop
virus
inhibit
postentri
step
treatment
cell
infect
mcmv
influenza
viru
iav
result
small
plaqu
phenotyp
wherea
total
number
plaqu
impact
thu
like
affect
infect
viral
inoculum
rather
impair
abil
viru
spread
result
indic
postentri
inhibit
viru
infect
possibl
stage
cellcel
spread
shown
author
varicella
zoster
viru
infect
somewhat
differ
conclus
two
studi
regard
mechan
action
may
repres
differ
experiment
condit
exampl
blanc
et
al
use
delipid
media
studi
liu
et
al
use
normal
serumcompl
media
differenti
effect
media
formul
context
antivir
mechan
unclear
nonetheless
like
exert
antivir
activ
multipl
stage
viral
life
cycl
case
mcmv
infect
evid
present
srebpdepend
srebpindepend
mode
antivir
action
studi
implic
addit
postentri
role
includ
inhibit
virusinduc
cellcel
fusion
syncytia
format
viru
spread
addit
found
interfer
replic
hcv
possibl
alter
lipid
composit
membran
replic
compart
protein
prenyl
pezacki
et
al
similar
mechan
may
respons
effect
virus
mcmv
thu
attribut
modul
viru
infect
mani
level
interferoninduc
transmembran
protein
ifitm
part
famili
structur
relat
protein
basal
express
mani
cell
type
induc
higher
level
express
ifn
variou
ifitm
exhibit
inhibitori
activ
multipl
envelop
virus
prior
fusion
common
subset
inhibit
virus
appear
share
cellular
locat
virion
fusion
review
diamond
farzan
exampl
inhibit
fusion
influenza
viru
iav
dengu
viru
west
nile
virus
fuse
late
endosom
le
preferenti
inhibit
ebolaviru
sever
acut
respiratori
syndrom
sar
coronaviru
fuse
lysosom
brass
et
al
feeley
et
al
huang
et
al
particularli
import
control
iav
vivo
knockout
mice
enhanc
patholog
follow
iav
infect
bailey
et
al
human
rare
allel
reduc
antiiav
efficaci
identifi
hospit
patient
present
sever
influenza
bailey
et
al
everitt
et
al
ifitm
gener
restrict
viral
fusion
plasma
membran
recycl
endosom
support
model
wherein
site
fusion
determin
ifitm
antivir
activ
sar
coronaviru
typic
restrict
viru
infect
trigger
multipl
innat
immun
defens
modul
membran
composit
includ
homodim
format
target
vapa
le
mvb
increas
cholesterol
lbpa
level
express
er
synthesi
secret
plasma
membran
accumul
decreas
intracellular
cholesterol
prevent
virion
hemifus
endosom
compart
modul
lipid
composit
viral
cellular
membran
ee
earli
endosom
becom
resist
restrict
pretreat
trypsin
enabl
plasma
membran
fusion
huang
et
al
ifitm
protein
primarili
local
cytosol
vesicl
includ
le
data
led
hypothesi
ifitm
may
modifi
either
ph
lipid
composit
le
lysosom
render
resist
fusion
ifitm
particularli
also
local
plasma
membran
follow
overexpress
interferon
induct
thu
also
effici
inhibit
cellcel
fusion
syncytia
format
hcv
coreceptor
interact
hiv
replic
postentri
step
lu
et
al
wilkin
et
al
recent
propos
ifitm
inhibit
viral
hemifus
express
block
cell
membran
hemifus
induc
class
viral
fusion
protein
alter
membran
composit
oleic
acid
induc
neg
membran
curvatur
favor
hemifus
overcam
ifitmmedi
restrict
cell
fusion
ifitm
express
alter
biophys
properti
membran
membran
ifitmexpress
cell
increas
lipid
pack
thu
decreas
fluid
dynam
assess
fluoresc
polar
approach
alter
membran
fluiditi
would
inhibit
hemifus
increas
free
energi
requir
induc
neg
membran
curvatur
mechan
prevent
hemifus
propos
requir
homoand
heteromer
interact
map
topolog
use
site
posttransl
modif
suggest
model
wherein
n
c
termini
cytosol
flank
two
intramembran
domain
separ
conserv
cytosol
loop
yount
et
al
first
intramembran
domain
plu
conserv
cytosol
loop
compromis
domain
present
protein
mutagenesi
studi
show
ntermin
cytosol
domain
domain
essenti
function
amino
acid
intramembran
portion
domain
requir
ifitm
selfassoci
lead
model
wherein
homomer
interact
alter
endosom
membran
fluiditi
curvatur
figur
addit
ifitm
mechan
action
involv
perturb
intracellular
lipid
transport
aminibavilolyae
et
al
vesicleassoci
membran
protein
vamp
associ
protein
vapa
identifi
protein
use
yeast
twohybrid
system
vapa
interact
oxysterolbind
protein
osbp
transfer
cholesterol
endoplasm
reticulum
er
organel
vesicl
bind
vapa
via
second
transmembran
domain
bind
vapa
interfer
vapaosbp
interact
overexpress
alter
cellular
cholesterol
level
increas
accumul
cholesterol
lysobisphosphatid
acid
lbpa
le
multivesicular
bodi
mvb
compart
increas
endosom
cholesterol
lbpa
perturb
virion
fusion
chevalli
et
al
interact
appear
import
inhibit
vsv
iav
entri
case
vsv
infect
express
result
accumul
vsv
mvb
entri
process
suggest
block
fusion
author
propos
model
wherein
ifitm
bind
vapa
recruit
endosom
compart
transfer
cholesterol
lbpa
creat
lipid
environ
resist
virion
fusion
figur
lowdens
lipoproteinrel
receptor
antivir
host
protein
modul
virion
lipid
composit
impact
effici
viral
fusion
gudleskioregan
et
al
ubiquit
express
plasma
membran
protein
regul
cholesterol
efflux
import
accumul
plasma
membran
transient
increas
follow
hcmv
infect
associ
decreas
intracellular
cholesterol
inhibit
express
function
elev
intracellular
cholesterol
enhanc
infecti
hcmv
product
gudleskioregan
et
al
effect
due
increas
cholesterol
hcmv
virion
lead
enhanc
specif
infect
specul
increas
infect
due
enhanc
fusion
sinc
hcmv
fusion
requir
cholesterol
taken
togeth
data
suggest
induc
shortli
infect
decreas
intracellular
cholesterol
thu
alter
lipid
composit
viral
envelop
decreas
subsequ
fusion
capac
second
round
infect
figur
number
compound
identifi
potenti
broadspectrum
inhibitor
envelop
virus
propos
mechan
action
compound
target
differ
aspect
fusion
process
one
better
studi
compound
arbidol
approv
influenza
b
viru
treatment
russia
china
propos
modul
fusion
protein
interact
phospholipid
prevent
protein
conform
chang
requir
fusion
teissier
et
al
squalamin
cation
amphipath
sterol
isol
dogfish
shark
antivir
activ
vitro
vivo
also
affin
phospholipid
may
perturb
fusion
process
zasloff
et
al
inhibit
viral
fusion
modul
membran
lipid
composit
underscor
import
biophys
properti
virion
envelop
fusion
one
antivir
approach
design
small
molecul
resembl
fusion
inhibitori
lysophospholipid
synthet
compound
call
rigid
amphipath
fusion
inhibitor
rafi
design
physic
resembl
lysophospholipid
also
show
promis
inhibit
fusion
improv
toxic
pharmacokinet
profil
st
vincent
et
al
compound
insert
membran
predict
produc
posit
membran
curvatur
outer
leaflet
therebi
inhibit
hemifus
rhodanin
deriv
chemic
distinct
rafi
also
inhibit
replic
envelop
virus
target
membran
compon
wolf
et
al
interestingli
mechan
action
simpli
base
mimick
lipid
shape
lysophosphatidylcholin
lpc
intercal
lipid
bilay
act
photosensit
hydroxyl
fatti
acid
chain
unsatur
phospholipid
vigant
et
al
alter
physic
properti
membran
result
inhibit
virion
fusion
yet
anoth
approach
alter
lipid
composit
viral
entri
inhibit
target
cellular
lipid
synthesi
uptak
pathway
neimann
pick
npc
like
cholesterol
uptak
receptor
express
hepatocyt
enterocyt
inhibit
cholesterol
uptak
activ
fdaapprov
drug
ezetimib
block
hcv
hbv
infect
lucifora
et
al
sainz
et
al
case
hcv
inhibit
entri
prior
complet
fusion
cholesteroldepend
manner
although
specif
mechan
action
undefin
sainz
et
al
inhibit
sterol
biosynthesi
also
potenti
antivir
therapi
particular
statin
gener
well
toler
patient
broadspectrum
antivir
activ
vitro
accumul
evid
suggest
efficaci
treat
hcv
iav
infect
either
via
antivir
activ
immunomodulatori
effect
review
sheridan
et
al
walsh
discoveri
antivir
mechan
primarili
target
fusion
quit
recent
mani
question
excit
avenu
research
remain
case
least
four
major
question
remain
secret
oxysterol
permeat
membran
primari
target
membran
inhibit
virion
fusion
sinc
entri
alreadi
occur
infect
cell
two
nonexclus
possibl
remain
modif
neighbor
cellular
membran
paracrin
manner
altern
directli
neutral
intraor
extracellular
virion
ii
chemic
basi
fusion
inhibit
option
includ
exclus
cholesterol
alter
membran
fluid
dynam
lipid
pack
properti
iii
mechan
postfus
antivir
activ
lipid
requir
virtual
everi
stage
viral
life
cycl
multipl
potenti
intervent
point
addit
regul
sterol
biosynthesi
multipl
stage
suggest
potenti
indirect
role
antivir
regul
iv
shown
regul
innat
adapt
immun
respons
integr
two
arm
immun
system
orchestr
effect
antivir
respons
given
function
hydroxyl
fatti
acid
chain
one
wonder
whether
increas
hydroxyl
lipid
content
membran
gener
approach
inhibit
viral
fusion
case
ifitm
remain
question
basi
differ
antivir
properti
individu
recruit
vapa
distinct
endosom
compart
isg
modul
lipid
composit
locat
plasma
membran
inhibit
viral
fusion
final
although
ifitm
studi
focus
fusion
remain
possibl
may
also
inhibit
subsequ
event
viral
life
cycl
lipid
composit
intracellular
organel
like
import
membran
remodel
establish
site
replic
posit
strand
rna
virus
hcv
interact
vapa
requir
vapa
osbp
replic
addit
multipl
virus
access
mvb
part
egress
may
impact
ifitm
inhibit
later
stage
viral
life
cycl
would
provid
antivir
role
ifn
induct
ifitm
within
infect
cell
establish
environ
resist
viral
entri
naiv
cell
multipl
question
remain
regard
role
viral
infect
clear
elev
plasma
membran
level
follow
hcmv
infect
whether
regul
ifn
respons
although
investig
whether
alter
infect
envelop
virus
upregul
hiv
infect
cell
monocyt
longterm
nonprogressor
suggest
may
broadspectrum
antivir
activ
rashe
et
al
steb
et
al
final
anticip
expand
appreci
role
lipid
antivir
respons
infect
term
directli
inhibit
viral
infect
regul
adapt
inflammatori
respons
exampl
bioactiv
lipid
lipoxygenas
pathway
recent
discov
modul
iav
infect
polyunsatur
fatti
acid
pufa
lipid
mediat
inhibit
iav
infect
cell
cultur
morita
et
al
act
stage
earli
gene
express
prevent
export
viral
messeng
genom
rna
inhibit
interact
nuclear
export
factor
unknown
mechan
level
decreas
iav
infect
vivo
express
invers
correl
diseas
sever
tam
et
al
also
identifi
lipoxygenasederiv
metabolit
differenti
accumul
respons
iav
infect
vivo
importantli
accumul
correl
antivir
activ
resolut
inflamm
administr
iav
lung
infect
mice
reduc
viral
titer
improv
surviv
suggest
therapeut
potenti
thu
lipid
multipl
role
antivir
innat
adapt
respons
control
inflamm
potenti
develop
antivir
therapeut
